Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Discovery could pave way for a blood test to diagnose Alzheimer's before symptoms appear

Two decades or more before symptoms arise, plaques of a sticky protein called amyloid begin forming in the brains of people later diagnosed with Alzheimer's disease.

28 Jul 2020

Investigational drug for Alzheimer's disease may help autistic children

An extensive international study led by Prof. Illana Gozes of Tel Aviv University's Department of Human Molecular Genetics and Biochemistry found deposits of the tau protein typically found in Alzheimer's patients in tissues taken from the postmortem brain of a 7-year-old autistic child.

28 Jul 2020

Artificial intelligence can expedite Alzheimer's diagnosis, improve patient prognosis

Artificial intelligence (AI) could help to diagnose Alzheimer's faster and improve patient prognosis, a new study from the University of Sheffield has revealed.

28 Jul 2020

Study uses MRI imaging to assess the brain matter of WTC responder patients

Two studies led by Stony Brook University researchers to be presented virtually at the Alzheimer's Association International Conference on July 28, 2020, indicate that World Trade Center (WTC) first responders are at risk for developing dementia.

28 Jul 2020

Lithium in drinking water may have a protective effect against suicide

Naturally occurring lithium in public drinking water may have an anti-suicidal effect - according to a new study from Brighton and Sussex Medical School and the Institute of Psychiatry, Psychology & Neuroscience at King's College London.

27 Jul 2020

Flu vaccine may lower chances of getting Alzheimer's disease

People who received at least one flu vaccination were 17% less likely to get Alzheimer's disease over the course of a lifetime, according to researchers at The University of Texas Health Science Center at Houston.

27 Jul 2020

Study provides insight into evolution of amyloid-β oligomer with temporary salt crystals

Alzheimer's disease is the leading cause of dementia worldwide and a major cause of disability. Now, researchers at Osaka University and Hokkaido University have shown that repeated precipitation-dissolution events of salt crystals do occur even at low salt concentrations in nanoscales, and that it can accelerate the aggregation of the neurotoxic amyloid-β peptides implicated in its pathogenesis.

27 Jul 2020

Research may lead to improved treatments for mental health

The National Institutes of Health awarded Penn State researchers a $1.85 million grant to develop a new way to test if dysfunctions in certain areas of the brain lead to mental health complications and brain disorders. If proven, the research would lead to better mental health treatments.

25 Jul 2020

Study finds increasing rates of preventable hospitalizations among dementia patients

Older adults with dementia tend to be hospitalized more often than those without cognitive impairment.

24 Jul 2020

Neurotransmitter-derived lipidoids help carry drugs across the blood-brain barrier in mice

Biomedical engineers at the Tufts University School of Engineering have developed tiny lipid-based nanoparticles that incorporate neurotranmitters to help carry drugs, large molecules, and even gene editing proteins across the blood-brain barrier and into the brain in mice.

24 Jul 2020

UB study validates a novel pharmacological target for Alzheimer’s disease

A UB study published in the journal Neurotherapeutics has validated a new pharmacological target for Alzheimer's disease.

24 Jul 2020

Scientists discover how coronavirus enters cells without encountering immune system resistance

With an alarm code, we can enter a building without bells going off. It turns out that the SARS coronavirus 2 (SARS-CoV-2) has the same advantage entering cells. It possesses the code to waltz right in.

24 Jul 2020

Journal Of Parkinson's Disease announces recipients of first Parkinson Prize

The Journal of Parkinson's Disease and its publisher IOS Press are proud to announce the two articles that have won the first Parkinson Prize, recognizing these outstanding contributions to the advancement to Parkinson's disease research.

23 Jul 2020

Researchers assess the damage caused by microbubbles in brain injuries

Say there's a bomb attack on a military base. A few of the soldiers suffer concussions and other brain injuries. Could some of the injuries be caused by tiny bubbles that form and collapse within the skull during head trauma?

23 Jul 2020

Amyloid plaques may act as trigger for Alzheimer's disease

The brains of people living with Alzheimer's are riddled with plaques: protein aggregates consisting mainly of amyloid-beta.

23 Jul 2020

Erectile dysfunction drugs lower the accumulation of toxic proteins in zebrafish models

The aberrant buildup of misfolded proteins is a hallmark of a host of disorders, including neurodegenerative diseases such as Alzheimer's and Parkinson's.

22 Jul 2020

Study reveals brain network mechanism causing spatial memory impairment

Patients with Alzheimer's disease frequently suffer from spatial memory loss, such as no recognition of where they are, and forgetting where they put their belongings.

21 Jul 2020

Research suggests a possible new approach to treating neurodegenerative diseases

Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

21 Jul 2020

Chronic stress linked to racial discrimination may adversely impact cognition, Alzheimer's disease

Experiences of racism are associated with lower subjective cognitive function (SCF) among African-American women.

21 Jul 2020

Researchers receive $1.3 million grant to develop better treatments for Alzheimer's disease

Innovators at Purdue University have received new support as they work to develop solutions to what U.S. military officials call an alarming trend in dementia among wounded soldiers. The same researchers also seek solutions to better treat Alzheimer's disease.

21 Jul 2020

Alzheimer's Disease News and Research

Further Reading

Discovery could pave way for a blood test to diagnose Alzheimer's before symptoms appear

Investigational drug for Alzheimer's disease may help autistic children

Artificial intelligence can expedite Alzheimer's diagnosis, improve patient prognosis

Study uses MRI imaging to assess the brain matter of WTC responder patients

Lithium in drinking water may have a protective effect against suicide

Flu vaccine may lower chances of getting Alzheimer's disease

Study provides insight into evolution of amyloid-β oligomer with temporary salt crystals

Research may lead to improved treatments for mental health

Study finds increasing rates of preventable hospitalizations among dementia patients

Neurotransmitter-derived lipidoids help carry drugs across the blood-brain barrier in mice

UB study validates a novel pharmacological target for Alzheimer’s disease

Scientists discover how coronavirus enters cells without encountering immune system resistance

Journal Of Parkinson's Disease announces recipients of first Parkinson Prize

Researchers assess the damage caused by microbubbles in brain injuries

Amyloid plaques may act as trigger for Alzheimer's disease

Erectile dysfunction drugs lower the accumulation of toxic proteins in zebrafish models

Study reveals brain network mechanism causing spatial memory impairment

Research suggests a possible new approach to treating neurodegenerative diseases

Chronic stress linked to racial discrimination may adversely impact cognition, Alzheimer's disease

Researchers receive $1.3 million grant to develop better treatments for Alzheimer's disease

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News